Essex Bio-Technology Limited (1061.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 2.14B |
| Enterprise Value | 1.7B |
| P/E Ratio | 4.71 |
| PEG Ratio | 1.27 |
| Price/Sales Ratio | 0.83 |
| Price/Book Ratio | 0.62 |
| Enterprise/Revenue | 0.58 |
| Enterprise/EBITDA | 2.27 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | 0.18 |
| Operating Margin | 0.2 |
AD
Management Effectiveness
| Return On Assets | 0.09 |
| Return On Equity | 0.14 |
Income Statement
| Revenue | 1.81B |
| Revenue/Share | 3.2 |
| Gross Profit | 1.62B |
| EBITDA | 467.9M |
| Net Income | 318.09M |
| Diluted EPS | 0.56 |
Balance Sheet
| Total Cash | 784.14M |
| Total Cash/Share | 1.38 |
| Total Debt | 346.9M |
| Total Debt/Equity | 0.14 |
| Current Ratio | 2.11 |
| Book Value Per Share | 4.26 |
Price History
| 52-Week Change | -42.73 |
| 52-Week High | 6.12 |
| 52-Week Low | 2.55 |
| Moving Average 50 Days | 3.04 |
| Moving Average 200 Days | 3.97 |
Statistics
| Average Volume | 563,700 |
| Shares Outstanding | 567.01M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.14 |
| Trailing Annual Dividend Yield | 5.3 |
| Payout Ratio | 0.23 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
